drugset / Trial / NCT02989012

Phase IIaTrials of GanMaoKangNing Granules

NCT02989012

Phase 2 Unknown 96 enrolled Dalian Zhen-Ao Bio-Tech Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

Randomized, double-blind, double- simulation, positive drug-and-Placebo-Controlled, multicenter, phase IIa clinical trials Study about GanMaoKangNing Granules in improving the symptoms of influenza.

Timeline

Start
Primary completion
2019-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject GanMaoKangNing Granules Unknown
Comparator Oseltamivir Small molecule Oral

Indications